期刊文献+

大黄素荧光特性对荧光分析的影响 被引量:3

Effects of emodin on fluorescence analysis
下载PDF
导出
摘要 目的观察大黄素的荧光光谱特性,以探讨其在平滑肌细胞中干预后对荧光分析的影响。方法在体外培养平滑肌细胞中.加入大黄素干预后,对细胞周期、活性氧簇测定以及Annexin V标记等进行荧光分析方法的观察。采用激光共聚焦观察大黄素在细胞内的分布。结果大黄素的最大激发波长为400-465nm,最大发射波长为515-525nm。大黄素对绿色荧光有明显影响,而对红色荧光方法影响轻微。激光共聚焦显示大黄素在细胞内有选择性分布。结论大黄素的绿色荧光特性既可能干扰绿色荧光分析,但也能具有新的用途。 Purpose To study the characteristics of fluorescence of emodin and its effects on fluorescence analysis in smooth muscle cell (SMC). Methods In the cultured SMC, the accuracy of some fluorescence analysis, including cell cycle, reactive oxygen species determination, and Annexin V labeling, was determined after emodin treatment. Cellular distribution of emodin had also been observed by eonfoeal microscope. Results The maximal excitation wavelength was 400 - 465 nm and the maximal fluorescence spectrum was between 515 nm and 525 nm. The accuracy of the green fluorescence analysis other than red fluorescence analysis could be remarkably interferred with emodin itself. The cellular distribution of emodin was distinctly selective. Conclusions The fluorescence of emdoin is a two-edged sword: the interference of greed fluorescence analysis and new purposes.
出处 《复旦学报(医学版)》 CAS CSCD 北大核心 2006年第2期262-265,共4页 Fudan University Journal of Medical Sciences
基金 国家"836"计划(2002AA326110) 国家自然科学基金项目(30270545)资助
关键词 大黄素 荧光分析 细胞 激光共聚焦 emodin fluorescence analysis cell confocal microscope
  • 相关文献

参考文献9

  • 1Vargas F, Fraile G, Velasquez M, et al. Studies on the photostability and phototoxicity of aloe-emodin, emodin and rhein[J]. Pharmazie, 2002, 57(6):399
  • 2Soichiro F, Katsuya A, Kazutaka U, et al. Bone Marrow Monocyte Lineage Cells Adhere on Injured Endothelium in a Monocyte Chemoattractant Protein-1-Dependent Manner and Accelerate Reendothelialization as Endothelial Progenitor Cells[J]. Circ Res, 2003, 93(10):980
  • 3Shieh DE, Chen YY, Yen MH, et al. Emodin-induced apoptosis through p53-dependent pathway in human hepatoma cells[J]. Life Sci, 2004, 74(18):2279
  • 4Jing X, Ueki N, Cheng J, et al. Induction of apoptosis in hepatocellular carcinoma cell lines by emodin[J]. Jpn J Cancer Res, 2002, 93(8):874
  • 5Kingsley K, Huff JL, Rust WL, et al. ERK1/2 mediates PDGF-BB stimulated vascular smooth muscle cell proliferation and migration on laminin-5[J]. Biochem Biophys Res Commun, 2002, 293(3):1000
  • 6Kuo PL, Lin TC, Lin CC. The antiproliferative activity of aloe-emodin is through p53-dependent and p21-dependent apoptotic pathway in human hepatoma cell lines[J]. Life Sci, 2002, 71(16):1879
  • 7Yang J, Li H, Chen YY, et al. Anthraquinones sensitize tumor cells to arsenic cytotoxicity in vitro and in vivo via reactive oxygen species-mediated dual regulation of apoptosis[J]. Free Radic Biol Med, 2004, 37(12):2027
  • 8Chen YC, Shen SC, Lee WR, et al. Emodin induces apoptosis in human promyeloleukemic HL-60 cells accompanied by activation of caspase 3 cascade but independent of reactive oxygen species production[J]. Biochem Pharmacol, 2002, 64(12):1713
  • 9Ubbink-Kok T, Anderson JA, Konings WN. Inhibition of electron transfer and uncoupling effects by emodin and emodinanthrone in Escherichia coli[J]. Antimicrob Agents Chemother, 1986,30(1):147

同被引文献39

  • 1Kimura S, Ando T, Kojima K, et al. Ever-advancing chronic mye- loid leukemia treatment [ J ]. Int J Clin Oncol, 2014,19 ( 1 ) : 3 -9.
  • 2Arana-Trejo RM, Ruiz SE, Ignacio-Ibarra G, et al. BCR/ ABL p210 ,p190 and p230 fusion genes in 250 Mexican patients with chronic myeloid leukaemia (CML) [ J]. Clin Lab Haematol, 2002,24(3) :145 - 150.
  • 3O'Hare T, Eide CA, Deininger MW. Bcr-Abl kinase domain mutations, drug resistance, and the road to a cure for chronic myeloid leukemia[ J ]. Blood,2007,110 (7) :2 242 - 2 249.
  • 4Dulucq S, Bouchet S, Turcq B, et al. Muhidrug resistance gene (MDR1) polymorphisms are associated with major molecular responses to standard-dose imatinib in chronic myeloid leukemia [J]. Blood,2008,112(5) :2 024 -2 027.
  • 5Baccarani M, Deininger MW, Rosti G, et al. European Leukemia- Net recommendations for the management of chronic myeloid leukemia:2013 [ J]. Blood,2013,122 (6) :872 - 884.
  • 6Srinivas G, Babykutty S, Sathiadevan PP, et al. Molecular mecha- nism of emodin action : transition from laxative ingredient to an antitumor agent[J] Med Res Rev,2007,27 (5) :591 - 608.
  • 7Guo J, Li W, Shi H, et al. Synergistic effects of curcumin with emodin against the proliferation and invasion of breast cancer cells through upregulation of miR-34a [ J ]. Mol Cell Biochem, 2013,382 (1/2) : 103 - 111.
  • 8Huang XZ, Wang J, Huang C, et al. Emodin enhances cytotoxicity of chemotherapeutic drugs in prostate cancer cells:the mecha- nisms involve ROS-mediated suppression of muhidrug resistance and hypoxia inducible factor-1 [ J ]. Cancer Biol Ther, 2008,7 (3) :468 - 475.
  • 9Nicoletti I, Miglirati G, Pagliacei MC, et al. A rapid and simple method for measuring thymocyte apoptosis by propodium iodide staining and flow eytometry [ J ]. J lmmunol Methods, 1991,139 (2) :271 -279.
  • 10Turhan AG. STATS as a CML target: STATinib therapies [ J ]. Blood ,2011,117 ( 12 ) : 3 252 - 3 253.

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部